Vet Cancer Registry Oncology Links from the OncoSite Canine Round
Cell Tumors By Elizabeth A Nesbit Lymphoma in Animals by the Lymphoma Information Network
Not exact matches
Immune
cells modified
by CRISPR - Cas9 were inserted into a lung cancer patient at the West China Hospital in Chengdu in the hopes that they'll be able to fight
tumors, and 10 people total will receive injections of CRISPR re-engineered
cells in order to assess the method's safety.
Chicago, GenomeWeb — A new study
by researchers from Memorial Sloan Kettering Cancer Center has demonstrated the predictive power of an AR - V7 protein expression test using Epic Sciences» non-EPCAM-based circulating
tumor cell detection platform, which could help guide treatment decisions for men with metastatic castration - resistant prostate cancer.
Currently marketed for research use
by Biofluidica, the test's microfluidic channels use specific cancer antibodies to detect capture circulating
tumor cells.
Most of her liver had already been destroyed
by the
tumor cells.
TPA is a toxic chemical described as «a potent
tumor promoter in mouse skin»
by the Boston - based firm
Cell Signaling Technology.
Goji's are reported to have anti-aging properties and show anti-
tumor activities against various types of skin cancer
cells by inhibiting
tumor growth and inducing apoptosis.
Mogroside V has been found in research to have the ability to inhibit
tumor growth in pancreatic cancer
by interfering with the rapid dividing of cancer
cells, preventing angiogenesis (blood flow to the
tumor), and even promoting cancer
cell death (10).
Capsaicin additionally produced a significant deceleration of the development of prostate
tumors created simply
by those human
cell lines grown in mouse models.
Cancer: Flaxseed may protect against breast cancer, prostate cancer, and colon cancer
by inhibiting
tumor growth and blocking enzymes that are involved in the spread of
tumor cells.
A heckler interrupted Vice President Joe Biden during a speech on Saturday, alleging the VP's son Beau Biden was killed
by a
tumor caused
by radiation from
cell phones, which prompted boos from the audience.
Each factor involved in the
tumor response — whether it is the speed with which chemotherapeutic drugs reach the tissue or the degree to which
cells signal each other to grow — is characterized
by a mathematical equation that captures its essence.
«Cancer
cells disguise themselves
by switching off genes, new research reveals: A genome - wide map of the genes switched off in aggressive
tumors reveals a «signature».»
They did so
by including factors like the mechanical forces acting on the
cells and the
tumor's cellular heterogeneity.
An immune response, triggered
by foreign neural stem
cells, could actually help attack
tumors, says Evan Snyder, a stem
cell biologist at Sanford Burnham Prebys Medical Discovery Institute in San Diego, California, and one of the early pioneers of the idea of using stem
cells to attack
tumors.
Renal
cell carcinoma, also known
by the eponym Grawitz
tumor, is the most common form of kidney cancer arising from the renal tubule.
By comparing the results to
cells from paired normal tissue, researchers get a detailed molecular picture of the
tumor environment, including the types and activity levels of T
cells that are critical to the immunotherapy response.
«There was this initial thought that [circulating
tumor cells] are only present at late stage,» says Sollier - Christen, but she notes that in the past year, several studies using more sensitive techniques have found such
cells much earlier in
tumor development, even before the
tumor becomes visible
by conventional imaging techniques.
This pilot research builds on an earlier study
by Milovancev and collaborators that examined the ability of MRIs and CT angiograms to detect cancerous lesions related to FISS, and another study that looked at three methods for assessing margins for canine mast
cell tumors and soft tissue sarcomas.
EphA2 spreads cancer
by allowing malignant
cells to migrate from the primary
tumor into circulation and eventually to adhere to other tissues.
«We're interrogating the
tumor microenvironment,» she says, «
by looking at suppressive cues as well as
cells and secreted proteins that protect
tumors from the immune response.»
Chan's laboratory uses genomic analyses to identify neoantigens — novel peptides found only in
tumors that arise from mutations accumulated
by cancerous
cells.
«Used in cancer therapy, this process could increase the impact of a treatment
by heating the cancer
cells while introducing the drug compound into the
tumor.»
The diagnosis of cancer and study of disease progression is often accomplished
by examining a
tumor sample containing many billions or even trillions of
cells.
Metastasis, the strategy adopted
by tumor cells to transform into an aggressive form of cancer, are often associated with a gloomy prognosis.
A route used
by tumor cells to spread could be exploited to make stem
cells for regenerative medicine and cancer therapies
By analysing the early steps that precede
tumor formation, Alexandra Van Keymeulen and colleagues found that expression of oncogenic Pik3ca reactivates a multilineage differentiation program in adult stem
cells that resembles to an immature embryonic state.
This suggests that in patients, drug - resistant
tumor cells might be replaced
by drug - sensitive
tumor cells during the drug holiday.
Along with the study's co-first authors, Drs. Aayoung Hong and Gatien Moriceau, Lo hypothesized that if they could identify the key
tumor cell processes triggered
by withdrawal of MAPK inhibitors, then scientists can exploit these process with existing or investigational drugs to trigger the maximal levels of
tumor cell death immediately following cessation of the initial therapy.
Chemotherapy drugs designed to kill
tumors may actually encourage ovarian cancer
by stimulating the growth of
cells that give rise to the malignancy, a new study finds.
Inspired
by his own bout of leukemia to try to find a better cancer treatment, retired broadcasting station owner Kanzius guessed that as an alternative to chemotherapy, he could inject
tumors with metal ions, then use radio waves to heat the metal and destroy cancerous
cells.
Overexpression of ZNF217 provides an advantage to
tumor cells by allowing
cells to infinitely proliferate and turning down pathways that typically tell
cells to mature into functional
cells (bone, blood, skin
cells).
Their paper, which appears in Nature Communications, describes how an immune
cell recruited to the
tumor induces the programmed suicide, or apoptosis, of the killer T
cells harnessed
by many immunotherapies.
Traditional genetic approaches together with the new wealth of genomic information for both human and model organisms open up strategies
by which drugs can be profiled for their ability to selectively kill
cells in a molecular context that matches those found in
tumors.
When researchers injected fresh breast cancer
cells in the side opposite the original
tumor site, the disease didn't recur in any of the mice, as the cancer was rejected
by the immune system's memory.
The discovery of anticancer drugs is now driven
by the numerous molecular alterations identified in
tumor cells over the past decade.
Led
by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James), the retrospective study suggested that a pattern of molecules called microRNA (miRNA) in
tumor cells might predict patients» response to radiation therapy.
Researchers used tissue and blood samples to show that the gammopathy (a precursor to myeloma) in both mice and patients with Gaucher disease is triggered
by specific lipids, and that the antibodies made
by tumor cells in nearly a third of myeloma patients are directed against such lipids.
In the
Cell study, Dr. Massagué, with Fellow Manuel Valiente, PhD, and other team members, found that in mouse models of breast and lung cancer — two
tumor types that often spread to the brain — many cancer
cells that enter the brain are killed
by astrocytes.
NF - kB enables cancer
cells to survive the pro-apoptotic influence of
tumor necrosis factor that is released
by tumor infiltrating macrophages;
Rubinstein said checkpoint therapies work
by cutting the brake cables on the white bloods
cells that are inherently able to kill
tumor cells.
Potti and his colleagues began
by testing chemotherapy drugs on cultured
cell lines from human
tumors, such as from the lung, breast, or ovary.
With the
tumor in this vulnerable state, the researchers strike again
by shutting down the
cell's ability to mitigate the toxic stew it creates from its own deranged metabolism.
The research shows that ONA reduces the progression of malignant ovarian cancer
tumors by interfering with the pro-tumor function of myeloid
cells.
A
tumor cell might have one copy or three instead of the normal two copies — one provided
by each parent.
The team led
by Andreas Plückthun, Director of the Department of Biochemistry at the University of Zurich, involving postdoc Rastik Tamaskovic and PhD student Martin Schwill, has now found out why these antibodies merely slow
tumor growth rather than killing off the cancer
cells.
In addition to diminishing the
tumor's energy supply, the diet slows the growth of glioblastoma
cells by altering a cellular - signaling pathway that commonly occurs in cancers, according to the researchers.
An experimental drug in early development for aggressive brain
tumors can cross the blood - brain
tumor barrier, kill
tumor cells and block the growth of
tumor blood vessels, according to a study led
by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).
«Just as normal
cells with the same genome differentiate into many different
cell types, a single
tumor characterized
by specific genetic mutations can contain many different types of
cells — stem - like and more differentiated
cells — with the difference being rooted in their epigenetic information.
Using human - derived glioblastoma
cells in a mouse models, researchers found that the modified high - fat, low - carbohydrate diet increased life expectancy
by 50 percent while also reducing
tumor progression
by a similar amount.